Atlas Trials

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Clinical trial NCT00219726 · COMPLETED

Trial details

NCT number
NCT00219726
Sponsor
Poitiers University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2002-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.